AstraZeneca is likely to run an additional global trial to assess the efficacy of its COVID-19 vaccine using a lower dosage, its chief executive was quoted as saying on Thursday…

Read more »

The post CEO says AstraZeneca Likely to Run New Global Trial of COVID-19 Vaccine appeared first on Hamodia.

In related news:

  1. Half the U.S. Supply of Trump-Touted Virus Drug Now Cut Off
  2. Skin Rashes Reported as Symtom of COVID-19
  3. Scientists May Need Years to Identify Coronavirus Immunity
  4. U.S. Company Trials Coronavirus Vaccine in Australia
  5. Researchers Ask If Survivor Plasma Could Prevent Coronavirus